Don't listen to this guy or Zack's. Listen to Dr. Frost. I think the person that wrote the Zack's article has their head up their #$%$.
Dispose of at own risk. Folks shorting this stock are going to be very upset in the coming months and years. Investing is risky, stock trading is more risky, option and commodities is most risky.
The manufacturing company said they were trying to have a response to the FDA by April 15th. The FDA has 30 days after, so we have a ways to go yet. Best that OPK doesn't say anything, IMO. The stock will go up. I am not worried. :)
Long and patient since $4s.
Possibly. That's why this is a 1 yr hold - at a minimum. Or a person can try their luck trading this, which I would not. Too many good things in the pipeline for me to go in and out of this, and I would never consider shorting this stock. The increases will come, just need to be patient.
In since $4s. Long
If you don't know how to put someone on ignore, ask. I had 2 psots and then about 20 greyed-out (on ignore) this morning. Kinda sad but at least I don't see the OPK-bashing posts and the posts from people with ridiculous and immature IDs. That's why people moved to Uncle - mature, informative posts.
And not as long, starting in $4s. I've added since and my average is higher but, it's still good and will be much better in the next 1-2 years. :)
I don't feel like he would sell until some more products come online in the next few years. But, it's all guesses. Who knows what goes on in that business genius' mind. ;) I am sure he has a plan.
Long and patient.
This was posted on another site.
Program: Abstracts – Orals, Poster Previews, and Posters
This years ENDO 2016 Conference boded well for OPKO Health’s Biologic Division
Phase 2 results in growth hormone-deficient adults (5 months) demonstrated that a single weekly injection of MOD-4023 can replace 7 consecutive daily injections of commercial hGH. The Phase 2 study met all safety and tolerability endpoints at all doses for all participants.
A pivotal Phase 3 study in GHD adults is ongoing. A Phase 2 study in GHD children is completed, and preparations for the pivotal Phase 3 study in pediatric population are in place.
Hmm...not sure. I guess we'll have to wait and see. No matter what, the stock will be up a decent amount this time next year, IMO.
They don't know. They also don't know why they are shorting a clear winning stock. Sure, it may take 1-3 years to get to some higher price levels but those of us who are patient will reap the rewards. :)
Long since $4s.
It could've before now. Only ting holding back the approval is the observations made by the FDA of the 3rd party manufacturer who said they would fix and reply to by April 15. Nothing wrong with the drug itself.
But, Dr Frost said he's very confident of the approval.
Funny how there are thumbs down. Do those people not read the same articles? :) Silly to short this stock and surprising how many do.
I grabbed some more yesterday at $10.04 for my IRA because my cost basis is $2 higher than that. My regular account is about $8.50.
Nah. Not until the approval is finalized. Then we'll see hills and smaller valleys again until earnings and through next year. It will steadily creep up even though shorts will still try to hold it back. Silly but it's what happens.
The longs know patience will pay off in 1+ years.